| Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. |
20042715 |
J Natl Cancer Inst |
| Effects of blood collection conditions on ovarian cancer serum markers. |
18060075 |
PLoS One |
| Factors influencing serum CA125II levels in healthy postmenopausal women. |
11352859 |
Cancer Epidemiol Biomarkers Prev |
| Modes of inference for evaluating the confidence of peptide identifications. |
18067248 |
J Proteome Res |
| Peptide sequence confidence in accurate mass and time analysis and its use in complex proteomics experiments. |
19367719 |
J Proteome Res |
| Software platform for rapidly creating computational tools for mass spectrometry-based proteomics. |
19309175 |
J Proteome Res |
| Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery. |
18652693 |
J Transl Med |
| Use of high density antibody arrays to validate and discover cancer serum biomarkers. |
19383305 |
Mol Oncol |
